logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hiroya Taniguchi

Aichi Cancer Center Hospital
H指数:36
被引数:7,594

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study

基于循环肿瘤DNA的术前基因组特征和术后分子残留病灶检测对可切除结直肠癌寡转移的风险分层：PRECISION，一项前瞻性多中心研究

ESMO Open
IF8.3
2026-10-280
OA
S. Kobayashi; T. Takamoto; A. Shiomi; A. Takahashi; M. Shiozawa; H. Taniguchi; Y. Nishizawa; D. Nobuoka; S. Yasuta; T. Kato; K. Ando; A. Taketomi; Y. Takahashi; S. Natsume; T. Kojima; T. Nakamura; R. Mitani; M. Wakabayashi; T. Yoshino; Y. Nakamura
Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用：一项前瞻性单臂II期临床试验

Communications Medicine
IF6.3
2026-09-090
OAAI
Yoshinori Kagawa; Daisuke Kotani; Hiroya Taniguchi; Tadayoshi Hashimoto; Hideaki Bando; Naoki Takahashi; Tetsuya Hamaguchi; Akiyoshi Kanazawa; Takeshi Kato; Koji Ando; Hisateru Yasui; Eiji Shinozaki; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Satoshi Yuki; Yoshiaki Nakamura; Masashi Wakabayashi; Hiromichi Nakajima; Takashi Ohta; Takayuki Yoshino
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study

开发用于估算日本系统性癌症治疗自付费用及基于理赔数据的协议评估的可视化工具：VEST-Ca研究

Japanese Journal of Clinical Oncology
IF2.2
2026-08-010
PRE
Honda, Kazunori; Shimomura, Kazuhiro; Taniguchi, Hiroya; Kadowaki, Shigenori; Masuishi, Toshiki; Narita, Yukiya; Mizuno, Taro; Ando, Taiju; Ishizuka, Yasunobu; Umegaki, Sho; Ando, Masashi; Muro, Kei
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report

PD-L1扩增的食管鳞状细胞癌患者对作为免疫检查点抑制剂的尼鲁单抗再挑战治疗的反应：病例报告

Therapeutic Advances in Medical Oncology
IF4.2
2026-06-160
PRE
Hiroyuki Kodama; Toshiki Masuishi; Yasunobu Ishizuka; Tomoki Sakakida; Kazunori Honda; Yukiya Narita; Hiroya Taniguchi; Shigenori Kadowaki; Masashi Ando; Waki Hosoda; Kei Muro
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

Nature Medicine
IF50
2026-06-080
OAAI
Hideaki Bando; Jun Watanabe; Yusuke Takahashi; Masahito Kotaka; Nobuhisa Matsuhashi; Eiji Oki; Yoshito Komatsu; Manabu Shiozawa; Keiji Hirata; Yuji Miyamoto; Masanobu Takahashi; Kentaro Yamazaki; Dai Manaka; Akiyoshi Kanazawa; Yi-Hsin Liang; Kun-Huei Yeh; Yuko Watsuji; Yuko Yamamoto; Makoto Fukui; Shruti Sharma; Vasily N. Aushev; Adham Jurdi; Matthew Rabinowitz; Minetta C. Liu; Alexey Aleshin; Ichiro Takemasa; Daisuke Kotani; Akihiro Sato; Toshihiro Misumi; Yoshiaki Nakamura; Qian Shi; Hiroya Taniguchi; Takayuki Yoshino; Takeshi Kato
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

Kinugasa, Y.; Uehara, K.; Yamaguchi, K.; Saito, Y.; Murofushi, K.; Sugai, T.; Ishiguro, M.; Ishihara, S.; Ueno, H.; Oka, S.; 等. 日本结直肠癌协会（JSCCR）. 日本结直肠癌协会2024年结直肠癌治疗指南. 国际临床肿瘤学杂志, 2025, 30, 2410–2463. [Google Scholar] [CrossRef]

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
IF2.8
2025-11-011
PRE
Kinugasa, Yusuke; Uehara, Kay; Yamaguchi, Kensei; Saito, Yutaka; Murofushi, Keiko; Sugai, Tamotsu; Ishiguro, Megumi; Ishihara, Soichiro; Ueno, Hideki; Oka, Shiro; Kato, Takeshi; Kanemitsu, Yukihide; Kawakami, Hisato; Kobayashi, Hirotoshi; Sakamoto, Yoshihiro; Shiozawa, Manabu; Shiomi, Akio; Shinozaki, Eiji; Takiyama, Hirotoshi; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Hotta, Kinichi; Matsuda, Keiji; Murata, Kohei; Morita, Satoshi; Yamazaki, Kentaro; Yoshida, Masahiro; Yamaguchi, Naohiko; Kagawa, Hiroyasu; Yamauchi, Shinichi; Ajioka, Yoichi
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究：BRAVERY研究（EPOC1701）

ESMO Open
IF8.3
2025-10-090
OAAI
T. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究：一项前瞻性队列研究

Annals of Surgery
IF6.4
2025-09-260
OAAI
Ando, Koji MD, PhD; Hamabe, Atsushi MD, PhD; Nakamura, Yoshiaki MD, PhD; Watanabe, Jun MD, PhD; Hirata, Keiji MD, PhD; Kataoka, Kozo MD, PhD; Miyo, Masaaki MD, PhD; Kato, Kentaro MD; Akazawa, Naoya MD; Kagawa, Yoshinori MD, PhD; Yokota, Mitsuru MD, PhD; Yamazaki, Kentaro MD, PhD; Mishima, Saori MD, PhD; Yukami, Hiroki MD; Kotani, Daisuke MD, PhD; Bando, Hideaki MD, PhD; Laliotis, George MD, MHA, MPH, MBA; Sharma, Shruti PhD; Palsuledesai, Charuta C. PhD; Rabinowitz, Matthew PhD; Jurdi, Adham MD; Liu, Minetta C. MD; Aleshin, Alexey MD; Taniguchi, Hiroya MD, PhD; Takemasa, Ichiro MD, PhD; Kato, Takeshi MD, PhD; Yoshino, Takayuki MD, PhD; Oki, Eiji MD, PhD
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer

HIBRID：基于组织学的结直肠癌风险分层，结合深度学习和ctDNA

Nature Communications
IF15.7
2025-08-140
OAAI
Chiara M. L. Loeffler; Hideaki Bando; Srividhya Sainath; Hannah Sophie Muti; Xiaofeng Jiang; Marko van Treeck; Nic Gabriel Reitsam; Zunamys I. Carrero; Asier Rabasco Meneghetti; Tomomi Nishikawa; Toshihiro Misumi; Saori Mishima; Daisuke Kotani; Hiroya Taniguchi; Ichiro Takemasa; Takeshi Kato; Eiji Oki; Yuan Tanwei; Wankhede Durgesh; Sebastian Foersch; Hermann Brenner; Michael Hoffmeister; Yoshiaki Nakamura; Takayuki Yoshino; Jakob Nikolas Kather
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study

奥沙利铂和5-氟尿嘧啶联合多西他赛新辅助治疗食管癌期间发热性中性粒细胞减少症的最佳一级预防：一项回顾性队列研究

CANCER MEDICINE
IF3.1
2025-04-240
OAAI
Kumanishi, Ryosuke; Taniguchi, Hiroya; Nakazawa, Taiko; Ogata, Takatsugu; Matsubara, Yuki; Kodama, Hiroyuki; Nakata, Akinobu; Honda, Kazunori; Masuishi, Toshiki; Narita, Yukiya; Kadowaki, Shigenori; Ando, Masashi; Tajika, Masahiro; Abe, Tetsuya; Muro, Kei
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

NATURE MEDICINE
IF50
2024-09-161
OAAI
Nakamura, Yoshiaki; Watanabe, Jun; Akazawa, Naoya; Hirata, Keiji; Kataoka, Kozo; Yokota, Mitsuru; Kato, Kentaro; Kotaka, Masahito; Kagawa, Yoshinori; Yeh, Kun-Huei; Mishima, Saori; Yukami, Hiroki; Ando, Koji; Miyo, Masaaki; Misumi, Toshihiro; Yamazaki, Kentaro; Ebi, Hiromichi; Okita, Kenji; Hamabe, Atsushi; Sokuoka, Hiroki; Kobayashi, Satoshi; Laliotis, George; Aushev, Vasily N.; Sharma, Shruti; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Rabinowitz, Matthew; Bando, Hideaki; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Kotani, Daisuke; Mori, Masaki; Yoshino, Takayuki; Oki, Eiji
PRABITAS study: A pragmatic, randomized, phase III trial of biweekly vs. conventional use of trifluridine/tipiracil plus bevacizumab for refractory metastatic colorectal cancer

PRABITAS研究：一项关于三周一次与常规用法三氟尿idine/替吡拉塞联合贝伐珠单抗治疗难治性转移性结直肠癌的实用型、随机化、III期临床试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Sakakida, T.; Masuishi, T.; Mitani, S.; Asayama, M.; Makiyama, A.; Shimura, T.; Takeda, H.; Suwa, Y.; Yomoda, T.; Mushiake, H.; Okumura, Y.; Takano, Y.; Tajika, M.; Ando, M.; Muro, K.; Mishima, A.; Kudo, C.; Murotani, K.; Taniguchi, H.
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

CANCER DISCOVERY
IF33.3
2024-07-161
OAAI
Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Fujisawa, Takao; Imai, Mitsuho; Shibuki, Taro; Iida, Naoko; Ozaki, Hiroshi; Nonomura, Norio; Morizane, Chigusa; Iwata, Hiroji; Okano, Susumu; Yamagami, Wataru; Yamazaki, Naoya; Kadowaki, Shigenori; Taniguchi, Hiroya; Ueno, Makoto; Boku, Shogen; Oki, Eiji; Komatsu, Yoshito; Yuki, Satoshi; Makiyama, Akitaka; Otsuka, Tomoyuki; Hara, Hiroki; Okano, Naohiro; Nishina, Tomohiro; Sakamoto, Yasutoshi; Miki, Izumi; Kobayashi, Shin; Yuda, Junichiro; Kageyama, Shun-Ichiro; Nagamine, Michiko; Sakashita, Shingo; Sakamoto, Naoya; Yamashita, Riu; Koga, Yoshikatsu; Bando, Hideaki; Ishii, Genichiro; Kuwata, Takeshi; Park, Woong-Yang; Ohtsu, Atsushi; Yoshino, Takayuki

研究方向

暂未获取到该数据
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:4.9万
Y
Yoshiaki Nakamura
H 指数:40论文数:669被引数:9,240
H
Hideaki Bando
H 指数:42论文数:595被引数:7,335
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
T
Toshiki Masuishi
H 指数:24论文数:324被引数:2,981
D
Daisuke Kotani
H 指数:26论文数:365被引数:4,070
E
Eiji Oki
H 指数:70论文数:1,185被引数:1.8万
S
Shigenori Kadowaki
H 指数:36论文数:417被引数:6,936
K
Kentaro Yamazaki
H 指数:46论文数:557被引数:1.4万
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万